Natpara — Medical Mutual
Chronic hypoparathyroidism
Initial criteria
- Not well-controlled on calcium supplements and active forms of vitamin D alone; AND
- 25-hydroxyvitamin D stores are sufficient (before initiating Natpara therapy) per the prescribing physician; AND
- Serum calcium concentration is > 7.5 mg/dL before initiating Natpara therapy; AND
- Prescribed by or in consultation with an endocrinologist or a nephrologist; AND
- Patient is age ≥ 18 years
Reauthorization criteria
- Patient cannot be well-controlled on calcium supplements and active forms of Vitamin D alone; AND
- 25-hydroxyvitamin D stores are sufficient (during Natpara therapy) per the prescribing physician; AND
- The patient is responding to Natpara therapy (e.g., reduction in the patient’s oral calcium dose; reduction in the patient’s active vitamin D dose; maintenance of a stable albumin-corrected total serum calcium concentration)
Approval duration
365 days